# US 2024/0390704 A1 · A device for affecting vascular blood flow and methods thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0390704 A1
- Document ID: US20240390704A1
- Status: Published application
- Kind: A1
- Application number: 18/714,529
- Filed: 2022-11-29
- Published: 2024-11-28
- Earliest claimed: 2021-12-01
- Assignees: Novapulse Ltd
- Applicants: Novapulse Ltd
- Inventors: Shaul Ozeri; Gal Atarot; Shai Policker
- Web page: https://patentgrep.com/patent/US20240390704A1

## CPC

- A61F 2/482: {Electrical means}
- A61N 7/00: Ultrasound therapy (lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 {; using ultrasound for introducing media into the body A61M37/0092})
- A61B 5/0031: {Implanted circuitry}
- A61B 5/026: Measuring blood flow {(A61B3/1233, A61B3/1241 take precedence)}
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/6876: {Blood vessel}
- A61B 90/06: {Measuring instruments not otherwise provided for}
- A61F 2/481: {Acoustic or audible means}
- A61B 5/02: Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B 5/14539: {for measuring pH}
- A61N 2007/0004: {Applications of ultrasound therapy}
- A61N 2007/0026: {Stimulation of nerve tissue}
- A61N 2007/0047: {interstitial}
- A61N 2007/0052: {using the same transducer for therapy and imaging}
- A61N 2007/0073: {using multiple frequencies}
- A61N 2007/0078: {with multiple treatment transducers}
- A61N 2007/0095: {by modifying an excitation signal}
- A61N 2007/025: {interstitial}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

The present disclosure relates to an implantable device that delivers therapeutic energy to a patient. More specifically it relates to implantable ultrasonic devices adapted to affect vascular endothelium to induce at least one substance selected from Nitric Oxide, NO, and/or adenosine triphosphate (ATP) release. Furthermore, the present disclosure relates to the treatment of various medical conditions, such as pulmonary hypertension, peripheral arterial disease (PAD) and Asthma by enhancing local perfusion to specific target organs.

## Claims

### Claim at position 1

1-80. (canceled)

### Claim 81

A device adapted to be implanted adjacent to at least one vessel or tissue containing flowing blood, the device comprising:
at least one ultrasonic transducer configured to emit ultrasonic energy toward the at least one vessel or tissue, so as to cause a physiologic effect in the at least one vessel or tissue;
wherein the device is configured to be in communication with at least one on-skin remote controller positioned externally to the patient and configured to control the ultrasonic energy; and
wherein the device is configured to be in communication with at least one sensor configured to monitor at least one physiological state of the patient.

### Claim 82 (depends on 81)

The device according to claim 81, wherein the at least one ultrasonic transducer comprises an array of ultrasonic transducers.

### Claim 83 (depends on 82)

The device according to claim 82, wherein the array of ultrasonic transducers is configured to facilitate alignment of the ultrasonic energy relative to the at least one vessel or tissue.

### Claim 84 (depends on 81)

The device according to claim 81, wherein the ultrasonic energy is provided in at least two different frequencies of a carrier signal.

### Claim 85 (depends on 81)

The device according to claim 81, wherein the emitting of the ultrasonic energy is synchronized to a pulse wave signal.

### Claim 86 (depends on 81)

The device according to claim 81, wherein the at least one ultrasonic transducer is configured to function as an acoustic sensor and sense one or more acoustic waves generated by the at least one vessel or tissue.

### Claim 87 (depends on 81)

The device according to claim 81, comprising at least one coil configured to form an inductive link between the device and the at least one on-skin remote controller.

### Claim 88 (depends on 87)

The device according to claim 87, comprising:
at least one implant comprising the at least one coil; and
at least one pig tail comprising the at least one ultrasonic transducer;
wherein the at least one pig tail is configured to be wired or wirelessly connected to the at least one implant.

### Claim 89 (depends on 81)

The device according to claim 81, wherein the monitored physiological state comprises one or more of: position of the patient, physical activity of the patient, nitric oxide levels in the at least one vessel or tissue, tissue perfusion, medical treatment provided to the patient, and any combination thereof.

### Claim 90 (depends on 81)

The device according to claim 81, wherein the physiologic effect comprises one or more of: vasodilation, increase in local ATP, enhanced ATP release, increase in local nitric oxide, prolonged local nitric oxide effects, enhanced nitric oxide release from vascular endothelium, enhanced nitric oxide release from red blood cells, alteration in erythrocytes function, modification in oxygen release from hemoglobin, increase in blood temperature, modification in pH of blood, modulation in immune response of blood leucocytes, modulation of coagulation and/or thrombocyte function, modification in function of heme catalyst enzymes in the blood, improved bioavailability of medication, improved efficiency of a hemodialysis session, artery dilation, increased blood perfusion, and any combination thereof.

### Claim 91 (depends on 81)

The device according to claim 81, wherein upon change of the at least one physiological state one or more of the following is performed: (a) the device is activated and ultrasonic energy is emitted, such that an on-demand treatment is provided; (b) at least one parameter of the ultrasonic energy is amended, such that an as-needed treatment is provided; (c) a notification is generated.

### Claim 92 (depends on 81)

The device according to claim 81, wherein the device is configured to be automatically activated upon change of the at least one physiological state.

### Claim 93 (depends on 81)

The device according to claim 81, wherein the device comprises one or more of the at least one sensor.

### Claim 94

A system comprising:
at least one implantable device adapted to be implanted adjacent to at least one vessel or tissue containing flowing blood, the at least one implantable device comprising at least one ultrasonic transducer configured to emit ultrasonic energy toward the at least one vessel or tissue, so as to cause a physiologic effect in the at least one vessel or tissue;
at least one on-skin remote controller configured to be positioned externally to the patient and configured to control the ultrasonic energy; and
at least one sensor configured to monitor at least one physiological state of the patient;
wherein the at least one implantable device is configured to be in communication with the at least one on-skin remote controller and with the at least one sensor.

### Claim 95 (depends on 94)

The system according to claim 94, wherein the at least one on-skin remote controller is configured to collect data from the at least one sensor and perform at least one of: monitor the data, adjust a treatment provided to the patient, maintain the treatment provided to the patient as is, and any combination thereof.

### Claim 96 (depends on 95)

The system according to claim 95, wherein the data comprises one or more of: shape of a pulse wave signal, velocity of a pulse wave signal and a time delay between an ECG signal and the pulse wave signal.

### Claim 97 (depends on 94)

The system according to claim 94, wherein the at least one on-skin remote controller is configured to control at least one parameter of the ultrasonic energy, the at least one parameter being one or more of: phase, frequency, power, intensity, amplitude, timing, duration, and any combination thereof.

### Claim 98 (depends on 94)

The system according to claim 94, wherein the at least one sensor is configured to be one or more of: implanted in the patient, integrated within the implantable device, worn by the patient, integrated within the at least one on-skin remote controller, and any combination thereof.

### Claim 99 (depends on 94)

The system according to claim 94, wherein the at least one sensor comprises one or more of: an accelerometer, a temperature sensor, a pulse wave sensor and an electrocardiogram (ECG) sensor.

### Claim 100 (depends on 94)

The system according to claim 94, wherein one or more of the at least one implantable device and one or more of the at least one on-skin remote controller comprise at least one coil configured to form an inductive link between the at least one implantable device and the at least one on-skin remote controller.

### Claim 101

A method of treating a patient using an implantable device adapted to be implanted adjacent to at least one vessel or tissue containing flowing blood, the method comprising:
using at least one ultrasonic transducer of the implantable device, emitting ultrasonic energy toward the at least one vessel or tissue, so as to cause a physiologic effect in the at least one vessel or tissue;
using at least one sensor, monitoring at least one physiological state of the patient; and
using at least one on-skin remote controller, controlling at least one of an operation of the implantable device and one or more parameters of the emitted ultrasonic energy, based on data collected by the at least one sensor.
